Abstract
Although pharmaceutical companies have long shied away from research and development on drugs against maladies that mainly afflict the poor, 63 drug projects now under way are targeting these very diseases, thanks to the efforts of a raft of new "public-private partnerships." (Read more.)

This publication has 0 references indexed in Scilit: